[DOI] [PubMed] [Google Scholar] 55.Dembinska-Kiec A., Pallapies D., Simmet T., Peskar B.M., Peskar B.A
Body changes, fatigue, and poor recovery can reflect a wide variety of underlying causes, from low thyroid hormones to poor sleep or out-of-control stress
This makes it a more favorable option from a safety standpoint, particularly for patients who are newly diagnosed and whose medication regimen is still being established
The SURPASS clinical trials have shown mean HbA1c reductions ranging from 1.9% to 2.4% depending on the dose, with higher doses generally producing greater glycemic improvements
The protein problem: preventing muscle loss on semaglutide This section deserves its own detailed treatment because muscle loss is the most serious long-term risk of extended semaglutide use with poor nutrition